NCT06525220 · Interventional trial
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Overall registry status Active not recruiting
Phase 3
Conditions Head and Neck Squamous Cell Carcinoma
Delaware Valley sites
- Site 153 · Philadelphia, PA · Philadelphia County
- Site 154 · Philadelphia, PA · Philadelphia County
- Site 43 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory